搜尋概念
|
已選取的篩選器 |
搜尋結果
-
Article
Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus
Liu, W. C., Lin, C. P., Cheng, C. P., Ho, C. H., Lan, K. L., Cheng, J. H., Yen, C. J., Cheng, P. N., Wu, I. C., Li, I. C., Chang, B. C. H., Tseng, V. S., Chiu, Y. C. & Chang, T. T., 2016 一月 1, 於: Hepatology International. 10, 1, p. 147-157 11 p.研究成果: Article › 同行評審
6 引文 斯高帕斯(Scopus) -
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
Kao, J. H., Lee, Y. J., Heo, J., Ahn, S. H., Lim, Y. S., Peng, C. Y., Chang, T-T., Torbeyns, A., Hughes, E., Bhore, R. & Noviello, S., 2016 十月 1, 於: Liver International. 36, 10, p. 1433-1441 9 p.研究成果: Article › 同行評審
20 引文 斯高帕斯(Scopus) -
A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine
Lin, S. Y., Dhillon, V., Jain, S., Chang, T. T., Hu, C. T., Lin, Y. J., Chen, S. H., Chang, K. C., Song, W., Yu, L., Block, T. M. & Su, Y. H., 2011 九月, 於: Journal of Molecular Diagnostics. 13, 5, p. 474-484 11 p.研究成果: Article › 同行評審
19 引文 斯高帕斯(Scopus) -
Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive chronic hepatitis B patients
Cheng, C. P., Lee, P. F., Liu, W. C., Wu, I. C., Chin, C. Y., Chang, T. T. & Tseng, V. S., 2012 二月 27, 於: PloS one. 7, 2, e32553.研究成果: Article › 同行評審
4 引文 斯高帕斯(Scopus) -
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
Kao, J. H., Chien, R. N., Chang, T. T., Peng, C. Y., Hu, T. H., Lo, G. H., Wang, H. Y., Chen, J. J., Yang, J. C., Knox, S. J., Han, L., Mo, H., Mathias, A., Brainard, D. M., Sheen, I. S., Hsu, Y. C., Chu, C. J. & Chuang, W. L., 2016 八月 1, 於: Liver International. 36, 8, p. 1101-1107 7 p.研究成果: Article › 同行評審
20 引文 斯高帕斯(Scopus) -
Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis c associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
Ng, K. J., Tseng, C. W., Chang, T. T., Tzeng, S. J., Hsieh, Y. H., Hung, T. H., Huang, H. T., Wu, S. F. & Tseng, K. C., 2016 八月 1, 於: Clinical Interventions in Aging. 11, p. 1035-1041 7 p.研究成果: Article › 同行評審
6 引文 斯高帕斯(Scopus) -
Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents
Cheng, P. N., Liu, W. C., Tsai, H. W., Wu, I. C., Chang, T. T. & Young, K. C., 2011 四月 1, 於: Journal of Medical Virology. 83, 4, p. 602-607 6 p.研究成果: Article › 同行評審
39 引文 斯高帕斯(Scopus) -
Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
Tseng, C. W., Chang, T. T., Tzeng, S. J., Hsieh, Y. H., Hung, T. H., Huang, H. T., Wu, S. F. & Tseng, K. C., 2016 三月 17, 於: Clinical Interventions in Aging. 11, p. 327-334 8 p.研究成果: Article › 同行評審
3 引文 斯高帕斯(Scopus) -
Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during longterm entecavir therapy
Lin, T. C., Chiu, Y. C., Chiu, H. C., Liu, W. C., Cheng, P. N., Chen, C. Y., Chang, T. T. & Wu, I. C., 2018 二月 14, 於: World journal of gastroenterology. 24, 6, p. 725-736 12 p.研究成果: Article › 同行評審
3 引文 斯高帕斯(Scopus) -
Combined transarterial embolization/ chemoembolization-based locoregional treatment with sorafenib prolongs the survival in patients with advanced hepatocellular carcinoma and preserved liver function: A propensity score matching study
Chien, S. C., Chen, C. Y., Cheng, P. N., Liu, Y. S., Cheng, H. C., Chuang, C. H., Chang, T. T., Chiu, H. C., Lin, Y. J. & Chiu, Y. C., 2019, 於: Liver Cancer. 8, 3, p. 186-202 17 p.研究成果: Article › 同行評審
4 引文 斯高帕斯(Scopus) -
Contrast-induced acute kidney injury among patients with chronic kidney disease undergoing imaging studies: A meta-analysis
Lee, Y. C., Hsieh, C. C., Chang, T. T. & Li, C. Y., 2019 一月 1, 於: American Journal of Roentgenology. 213, 4, p. 728-735 8 p.研究成果: Article › 同行評審
4 引文 斯高帕斯(Scopus) -
DeF-GPU: Efficient and effective deletions finding in hepatitis B viral genomic DNA using a GPU architecture
Cheng, C. P., Lan, K. L., Liu, W. C., Chang, T. T. & Tseng, V. S., 2016 十二月 1, 於: Methods. 111, p. 56-63 8 p.研究成果: Article › 同行評審
4 引文 斯高帕斯(Scopus) -
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
Chiu, H. C., Chiu, Y. C., Yang, E. H., Chang, T. T., Chien, S. C., Wu, I. C., Wu, C. H. & Cheng, P. N., 2020, (Accepted/In press) 於: Journal of the Formosan Medical Association.研究成果: Article › 同行評審
開啟存取 -
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
Liu, C. J., Chuang, W. L., Sheen, I. S., Wang, H. Y., Chen, C. Y., Tseng, K. C., Chang, T. T., Massetto, B., Yang, J. C., Yun, C., Knox, S. J., Osinusi, A., Camus, G., Jiang, D., Brainard, D. M., McHutchison, J. G., Hu, T. H., Hsu, Y. C., Lo, G. H., Chu, C. J. 及其他4, , 2018 三月, 於: Gastroenterology. 154, 4, p. 989-997 9 p.研究成果: Article › 同行評審
54 引文 斯高帕斯(Scopus) -
Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24
Hsu, C. W., Chao, Y. C., Lee, C. M., Chang, T. T. & Chen, Y. C., 2012 十二月 13, 於: BMC Gastroenterology. 12, 178.研究成果: Article › 同行評審
7 引文 斯高帕斯(Scopus) -
Fucosyl-agalactosyl IgG1 induces cholangiocarcinoma metastasis and early recurrence by activating tumor-associated macrophage
Chang, T. T., Tsai, H. W. & Ho, C. H., 2018 十一月 21, 於: Cancers. 10, 11, 460.研究成果: Article › 同行評審
3 引文 斯高帕斯(Scopus) -
Fully galactosyl-fucosyl-bisected IgG 1 reduces anti-HBV efficacy and liver histological improvement
Ho, C. H., Chen, S. H., Tsai, H. W., Wu, I. C. & Chang, T. T., 2019 三月, 於: Antiviral Research. 163, p. 1-10 10 p.研究成果: Article › 同行評審
-
Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients
Liu, W. C., Wu, I. C., Chiu, Y. C., Tseng, K. C., Chen, C. Y., Chiu, H. C., Cheng, P. N. & Chang, T. T., 2020 四月, 於: Antiviral Research. 176, 104719.研究成果: Article › 同行評審
開啟存取 -
Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma
Yen, C. J., Lin, Y. J., Yen, C. S., Tsai, H. W., Tsai, T. F., Chang, K. Y., Huang, W. C., Lin, P. W., Chiang, C. W. & Chang, T. T., 2012 七月 27, 於: PloS one. 7, 7, e41931.研究成果: Article › 同行評審
44 引文 斯高帕斯(Scopus) -
High Rates of Viral Suppression After Long-term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B
Pan, C. Q., Tong, M., Kowdley, K. V., Hu, K. Q., Chang, T. T., Lai, C. L., Yoon, S. K., Lee, S. S., Cohen, D., Tang, H. & Tsai, N., 2012 九月, 於: Clinical Gastroenterology and Hepatology. 10, 9, p. 1047-1050.e1研究成果: Article › 同行評審
12 引文 斯高帕斯(Scopus) -
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis
Puoti, M., Foster, G. R., Wang, S., Mutimer, D., Gane, E., Moreno, C., Chang, T. T., Lee, S. S., Marinho, R., Dufour, J. F., Pol, S., Hezode, C., Gordon, S. C., Strasser, S. I., Thuluvath, P. J., Zhang, Z., Lovell, S., Pilot-Matias, T. & Mensa, F. J., 2018 八月, 於: Journal of Hepatology. 69, 2, p. 293-300 8 p.研究成果: Article › 同行評審
69 引文 斯高帕斯(Scopus) -
Identification of hnRNPH1, NF45, and C14orf166 as novel host interacting partners of the mature hepatitis C virus core protein
Lee, J. W., Liao, P. C., Young, K. C., Chang, C. L., Chen, S. S. L., Chang, T. T., Lai, M. D. & Wang, S. W., 2011 十月 7, 於: Journal of Proteome Research. 10, 10, p. 4522-4534 13 p.研究成果: Article › 同行評審
30 引文 斯高帕斯(Scopus) -
Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma
Kuo, H. Y., Chiang, N. J., Chuang, C. H., Chen, C. Y., Wu, I. C., Chang, T. T., Tsai, H. M. & Lin, Y. J., 2020 五月 1, 於: Oncology Research and Treatment. 43, 5, p. 211-220 10 p.研究成果: Article › 同行評審
-
Impact of increasing alanine aminotransferase levels within normal range on incident diabetes
Wang, C. S., Chang, T. T., Yao, W. J., Wang, S. T. & Chou, P., 2012 四月, 於: Journal of the Formosan Medical Association. 111, 4, p. 201-208 8 p.研究成果: Article › 同行評審
30 引文 斯高帕斯(Scopus) -
Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma
Jain, S., Chen, S., Chang, K. C., Lin, Y. J., Hu, C. T., Boldbaatar, B., Hamilton, J. P., Lin, S. Y., Chang, T. T., Chen, S. H., Song, W., Meltzer, S. J., Block, T. M. & Su, Y. H., 2012 四月 20, 於: PloS one. 7, 4, e35789.研究成果: Article › 同行評審
30 引文 斯高帕斯(Scopus) -
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus
Chuang, W. L., Chien, R. N., Peng, C. Y., Chang, T. T., Lo, G. H., Sheen, I. S., Wang, H. Y., Chen, J. J., Yang, J. C., Knox, S. J., Gao, B., Garrison, K. L., Mo, H., Pang, P. S., Hsu, Y. C., Hu, T. H., Chu, C. J. & Kao, J. H., 2016 七月 1, 於: Journal of Gastroenterology and Hepatology (Australia). 31, 7, p. 1323-1329 7 p.研究成果: Article › 同行評審
22 引文 斯高帕斯(Scopus) -
Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901
Manns, M. P., Akarca, U. S., Chang, T. T., Sievert, W., Yoon, S. K., Tsai, N., Min, A., Pangerl, A., Beebe, S., Yu, M. & Wongcharatrawee, S., 2012 五月 1, 於: Expert Opinion on Drug Safety. 11, 3, p. 361-368 8 p.研究成果: Article › 同行評審
42 引文 斯高帕斯(Scopus) -
Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma
Jain, S., Chang, T. T., Hamilton, J. P., Lin, S. Y., Lin, Y. J., Evans, A. A., Selaru, F. M., Lin, P. W., Chen, S. H., Block, T. M., Hu, C. T., Song, W., Meltzer, S. J. & Su, Y. H., 2011 十一月 2, 於: PloS one. 6, 11, e26799.研究成果: Article › 同行評審
25 引文 斯高帕斯(Scopus) -
Novel nucleotide and amino acid covariation between the 5′UTR and the NS2/NS3 proteins of hepatitis C virus: Bioinformatic and functional analyses
Sun, H. Y., Ou, N. Y., Wang, S. W., Liu, W. C., Cheng, T. F., Shr, S. J., Sun, K. T., Chang, T. T. & Young, K. C., 2011 九月 28, 於: PloS one. 6, 9, e25530.研究成果: Article › 同行評審
5 引文 斯高帕斯(Scopus) -
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
LIRA-B Study Team, 2016 五月 1, 於: Journal of Hepatology. 64, 5, p. 1011-1019 9 p.研究成果: Article › 同行評審
30 引文 斯高帕斯(Scopus) -
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma
Chang, T. T. & Ho, C. H., 2020 八月, 於: PloS one. 15, 8 August, e0238251.研究成果: Article › 同行評審
開啟存取 -
Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas
Chang, T. T., Cheng, J. H., Tsai, H. W., Young, K. C., Hsieh, S. Y. & Ho, C. H., 2019 七月, 於: Journal of Pathology: Clinical Research. 5, 3, p. 199-212 14 p.研究成果: Article › 同行評審
開啟存取2 引文 斯高帕斯(Scopus) -
Prediction of early hepatocellular carcinoma recurrence using germinal center kinase-like kinase
Ho, C. H., Chuang, H. C., Wu, I. C., Tsai, H. W., Lin, Y. J., Sun, H. Y., Young, K. C., Chiu, Y. C., Cheng, P. N., Liu, W. C., Tan, T. H. & Chang, T. T., 2016, 於: Oncotarget. 7, 31, p. 49765-49776 12 p.研究成果: Article › 同行評審
3 引文 斯高帕斯(Scopus) -
Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma
Tsai, H. W., Ho, C. L., Cheng, S. W., Lin, Y. J., Chen, C. C., Cheng, P. N., Yen, C. J., Chang, T. T., Chiang, P. M., Chan, S. H., Ho, C. H., Chen, S. H., Wang, Y. W., Chow, N. H. & Lin, J. C., 2018 三月 14, 於: World journal of gastroenterology. 24, 10, p. 1152-1166 15 p.研究成果: Article › 同行評審
4 引文 斯高帕斯(Scopus) -
Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma
Tsai, H. W., Lin, Y. J., Wu, H. C., Chang, T. T., Wu, I. C., Cheng, P. N., Yen, C. J., Chan, S. H., Huang, W. & Su, I. J., 2016 五月 10, 於: Oncotarget. 7, 19, p. 27724-27734 11 p.研究成果: Article › 同行評審
12 引文 斯高帕斯(Scopus) -
Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis
Ho, C. H., Chang, T. T. & Chien, R. N., 2019 十一月 1, 於: PloS one. 14, 11, e0225482.研究成果: Article › 同行評審
開啟存取 -
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
Liaw, Y. F., Sheen, I. S., Lee, C. M., Akarca, U. S., Papatheodoridis, G. V., Suet-Hing Wong, F., Chang, T. T., Horban, A., Wang, C., Kwan, P., Buti, M., Prieto, M., Berg, T., Kitrinos, K., Peschell, K., Mondou, E., Frederick, D., Rousseau, F. & Schiff, E. R., 2011 一月, 於: Hepatology. 53, 1, p. 62-72 11 p.研究成果: Article › 同行評審
252 引文 斯高帕斯(Scopus) -
Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient's viremia
Tsai, P., Lin, C. C., Sun, H. Y., Lee, J. C., Chang, T. T. & Young, K. C., 2018 八月, 於: Journal of Microbiology, Immunology and Infection. 51, 4, p. 446-455 10 p.研究成果: Article › 同行評審
4 引文 斯高帕斯(Scopus) -
Conference contribution
Discovering clinical biomarkers of chronic hepatitis B by mining mutation hotspots
Cheng, C. P., Lee, P. F., Chin, C. Y., Liu, W. C., Wu, I. C., Chang, T. T. & Tseng, V. S., 2011 十二月 1, Proceedings - 2011 Conference on Technologies and Applications of Artificial Intelligence, TAAI 2011. p. 51-56 6 p. 6120719. (Proceedings - 2011 Conference on Technologies and Applications of Artificial Intelligence, TAAI 2011).研究成果: Conference contribution
2 引文 斯高帕斯(Scopus) -
Review article
Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations
Wu, I. C., Liu, W. C. & Chang, T. T., 2018 六月 2, 於: Journal of biomedical science. 25, 1, 51.研究成果: Review article › 同行評審
6 引文 斯高帕斯(Scopus)